Methods for treating tumor-induced osteomalacia
US11771748B2 · kind B2 · utility
1Cited by
14References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 12, 2021 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Nov 12, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for treating tumor-induced osteomalacia. The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.